Detection and evaluation of dyslipoproteinemia

Endocrinology and Metabolism Clinics of North America

Volumn 27, Issue 3, 1998, Pages 597-611

  Cleeman, J I ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CORONARY RISK; DYSLIPOPROTEINEMIA; HEALTH PROGRAM; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; MORTALITY; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW;

EID: 0031663603     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70028-1     Document Type: Article

References (40)

1. K.M. Anderson W.P. Castelli D. Levy Cholesterol and mortality: 30 years of follow-up from the Framingham Study JAMA 257 1987 2176
2. M.A. Austin J.E. Hokanson K.L. Edwards Hypertriglyceridemia as a cardiovascular risk factor Am J Cardiol 81 4A 1998 7B
3. F.C. Ballantyne D.A. Melville J.P. McKenna Response of plasma lipoproteins and acute phase proteins to myocardial infarction Clin Chim Acta 99 1979 85
4. Corti M.-C. J.M. Guralnik M.E. Salive HDL cholesterol predicts coronary heart disease mortality in older persons JAMA 274 1995 539
5. M.A. Denke Cholesterol-lowering diets: A review of the evidence Arch Intern Med 155 1995 17
6. Downs JR, Clearfield M, Whitney E, et al: Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Preliminary results. Reported at the American Heart Association 70th Scientific Sessions, Orlando, FL, November 12, 1997.
7. P.J. Elton J. Ryman M. Hammer Randomised controlled trial in northern England of the effect of a person knowing their own serum cholesterol concentration J Epidemiol Community Health 48 1994 22
8. Expert Panel National Cholesterol Education Program: Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Circulation 89 1994 1329
9. Expert Panel: National Cholesterol Education Program: Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Bethesda, MD, National Heart, Lung, and Blood Institute, NIH (NIH Publication No. 93-3095), 1993.
10. Expert Panel Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults JAMA 269 1993 3015
11. Federation of American Societies for Experimental Biology, Life Sciences Research Office Third Report on Nutrition Monitoring in the United States vol 1 1995 US Government Printing Office Washington, DC
12. W.T. Friedewald R.I. Levy D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499
13. D.J. Gordon Cholesterol lowering and total mortality Rifkind B.M. Lowering Cholesterol in High-Risk Individuals and Populations 1995 Marcel Dekker New York
14. S.M. Grundy Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome Am J Cardiol 81 4A 1998 18B
15. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults: American College of Physicians Ann Intern Med 124 1996 515
16. R.J. Havel Analysis of angiographic trial data in women Drugs 47 2 1994 11
17. P.R. Hebert J.M. Gaziano K.S. Chan Cholesterol lowering with statin drugs, risk of stroke, and total mortality: An overview of randomized trials JAMA 278 1997 313
18. C.L. Johnson B.M. Rifkind C.T. Sempos Declining serum cholesterol levels among US adults: The National Health and Nutrition Examination Surveys JAMA 269 1993 3002
19. W.B. Kannel A. Schatzkin Sudden death: Lessons from subsets in population studies J Am Coll Cardiol 5 1985 141B
20. M.J. Klag D.E. Ford L.A. Mead Serum cholesterol in young men and subsequent cardiovascular disease N Engl J Med 328 1993 313
21. L. Kuller N. Borhani C. Furberg Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study Am J Epidemiol 139 1994 1164
22. Kuller LH: Magnitude of the problem. In Proceedings of the National Heart, Lung, and Blood Institute Symposium on Rapid Identification and Treatment of Acute Myocardial Infarction. Bethesda, MD, National Heart, Lung, and Blood Institute, NIH, 1992.
23. M.R. Law N.J. Wald S.G. Thompson By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease BMJ 308 1994 367
24. S.J. Lewis J.S. Mitchell C. East Women in CARE have earlier and greater response to pravastatin post myocardial infarction [abstract 0069] Circulation 94 I 1996 I-12
25. T.A. Manolio T.A. Pearson N.K. Wenger Cholesterol and heart disease in older persons and women: Review of an NHLBI workshop Ann Epidemiol 2 1992 161
26. McGill H.C. Jr C.A. McMahan Malcom G.T. for the PDAY Research Group Effects of serum lipoproteins and smoking on atherosclerosis in young men and women Arterioscler Thromb Vasc Biol 17 1997 95
27. T.A. Miettinen T. Pedersen K. Pyorala Cholesterol lowering with simvastatin reduced major coronary events, revascularization procedures and cardiovascular hospitalizations in women participating in the Scandinavian Simvastatin Survival Study (4S) [abstract 0068] Circulation 94 I 1996 I-12
28. Morbidity and Mortality 1996 Chartbook on Cardiovascular, Lung, and Blood Diseases 1996 National Heart, Lung, and Blood Institute, NIH Bethesda, MD
29. National Heart, Lung, and Blood Institute Cholesterol Awareness Surveys, 1995. Bethesda, MD, National Heart, Lung, and Blood Institute, Press Conference, December 4, 1995.
30. J.D. Neaton D. Wentworth Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease Arch Intern Med 152 1992 56
31. NIH Consensus Development Panel Triglyceride, high-density lipoprotein, and coronary heart disease JAMA 269 1993 505
32. T.R. Pedersen J. Kjekshus K. Pyorala Effect of simvastatin on survival and coronary morbidity in coronary heart disease patients 65 or older [abstract 3225] Circulation 92 I 1995 I-672
33. S.M. Rubin S. Sidney D.M. Black High blood cholesterol in elderly men and the excess risk for coronary heart disease Ann Intern Med 113 1990 916
34. R.E. Ryder T.M. Hayes I.P. Mulligan How soon after myocardial infarction should plasma lipid values be assessed? BMJ 289 1984 1651
35. F.M. Sacks M.A. Pfeffer Moye L.A. the Cholesterol and Recurrent Events Trial Investigators The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1995 1001
36. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383
37. Scientific Steering Committee on behalf of the Simon Broome Register Group Risk of fatal coronary heart disease in familial hypercholesterolemia BMJ 303 1991 893
38. C.T. Sempos J.I. Cleeman M.K. Carroll Prevalence of high blood cholesterol among US adults: An update based on guidelines from the Second Report of the National Cholesterol Education Program Adult Treatment Panel JAMA 269 1993 3009
39. J. Shepherd S.M. Cobbe Ford I. for the West of Scotland Coronary Prevention Study Group Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301
40. P.W.F. Wilson R.D. Abbott W.P. Castelli High density lipoprotein cholesterol and mortality: The Framingham Heart Study Arteriosclerosis 8 1988 737